COPD Trial, Recruiting (NCT05922202)

COPD Trial, Recruiting NCT05922202 Sponsor: Azienda Ospedaliero-Universitaria di Modena Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT05922202 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older and have been diagnosed with COPD (a lung condition) for at least 1 year
Your COPD has been stable, meaning you have not had a sudden worsening of symptoms in the last 30 days and have not been hospitalised for any reason in the last 3 months
You have a smoking history of at least 10 "pack-years" (this is a way of measuring how much you have smoked over time — confirm with trial site if unsure)
Your COPD has been diagnosed following standard international guidelines for COPD
You are able to read, understand, and sign a consent form agreeing to take part

Who may not be able to join:

You have also been diagnosed with a scarring or thickening lung disease (called interstitial lung disease)
Your breathing test (spirometry) shows a "restrictive" pattern, meaning your lungs have difficulty fully expanding (confirm with trial site)
You have never smoked in your life
You are unable to provide written consent to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alessia Verduri, PhD, Respiratory Unit-University of Modena (Italy) - Hospital Policlinico Modena

Phone: +390594225769

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05922202

Sponsor: Azienda Ospedaliero-Universitaria di Modena

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: +390594225769

More information: https://clinicaltrials.gov/study/NCT05922202

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older and have been diagnosed with COPD (a lung condition) for at least 1 year
Your COPD has been stable, meaning you have not had a sudden worsening of symptoms in the last 30 days and have not been hospitalised for any reason in the last 3 months
You have a smoking history of at least 10 "pack-years" (this is a way of measuring how much you have smoked over time — confirm with trial site if unsure)
Your COPD has been diagnosed following standard international guidelines for COPD
You are able to read, understand, and sign a consent form agreeing to take part

Who may not be able to join:

You have also been diagnosed with a scarring or thickening lung disease (called interstitial lung disease)
Your breathing test (spirometry) shows a "restrictive" pattern, meaning your lungs have difficulty fully expanding (confirm with trial site)
You have never smoked in your life
You are unable to provide written consent to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Azienda Ospedaliero-Universitaria di Modena

Registry

ClinicalTrials.gov

Start date

23 February 2024

Est. completion

15 November 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Number of cardiovascular events in COPD patients living with frailty vs non-frail COPD. patients.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov